These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1078550)

  • 21. Experiences with thymosin in primary immunodeficiency disease.
    Astaldi A; Astaldi GC; Wijermans P; Dagna-Bricarelli F; Kater L; Stoop JW; Vossen JM
    Cancer Treat Rep; 1978 Nov; 62(11):1779-85. PubMed ID: 215306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosette-forming cells, immunologic deficiency diseases and transfer factor.
    Wybran J; Levin AS; Spitler LE; Fudenberg HH
    N Engl J Med; 1973 Apr; 288(14):710-3. PubMed ID: 4540063
    [No Abstract]   [Full Text] [Related]  

  • 23. [Use of thymus gland peptides in chronic cholecystitis].
    Rodoman GV; Belousov IuB; Kostrova MV; Petrov OA
    Sov Med; 1991; (3):73-4. PubMed ID: 1882302
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of thymic factors on the differentiation of human marrow cells into T-lympnocytes in vitro in normals and patients with immunodeficiencies.
    Touraine JL; Touraine F; Incefy GS; Good RA
    Ann N Y Acad Sci; 1975 Feb; 249():335-42. PubMed ID: 48353
    [No Abstract]   [Full Text] [Related]  

  • 25. Purification and properties of bovine thymosin.
    Hooper JA; McDaniel MC; Thurman GB; Cohen GH; Schulof RS; Goldstein AL
    Ann N Y Acad Sci; 1975 Feb; 249():125-44. PubMed ID: 236717
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro studies on human T-lymphocyte differentiation in primary immunodeficiency diseases.
    Incefy GS; Touraine JL; Touraine F; L'esperance P; Siegal FP; Good RA
    Trans Assoc Am Physicians; 1974; 87():258-62. PubMed ID: 4549143
    [No Abstract]   [Full Text] [Related]  

  • 27. Human thymus lymphoid tissue (HTL) antigen, complement receptor and rosette formation with sheep erythrocytes of the lymphocytes from primary immunodeficiency diseases.
    Yata J; Tsukimoto I; Arimoto T; Goya N; Tachibana T
    Clin Exp Immunol; 1973 Jul; 14(3):309-17. PubMed ID: 4579777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influenza: response of T-cell lymphopenia to thymosin.
    Scheinberg M; Blacklow NR; Goldstein AL; Parrino TA; Rose FB; Cathcart ES
    N Engl J Med; 1976 May; 294(22):1208-11. PubMed ID: 1083484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of thymus gland preparations on T- and B-lymphocytes in experimental tuberculosis].
    Kononko IV
    Probl Tuberk; 1986; (2):55-8. PubMed ID: 3486412
    [No Abstract]   [Full Text] [Related]  

  • 30. [Endocrine function of the thymus].
    Kostadinov D
    Vutr Boles; 1975; 14(5):11-20. PubMed ID: 772972
    [No Abstract]   [Full Text] [Related]  

  • 31. Thymosin and the immunopathology of aging.
    Goldstein AL; Hooper JA; Schulof RS; Cohen GH; Thurman GB; McDaniel MC; White A; Dardenne M
    Fed Proc; 1974 Sep; 33(9):2053-6. PubMed ID: 4547564
    [No Abstract]   [Full Text] [Related]  

  • 32. [Clinical and experimental justification for using thymus preparations for the treatment of infectious and allergic diseases of the respiratory organs caused by changes in the thymus-dependent immunity system].
    Giulling EV
    Zh Ushn Nos Gorl Bolezn; 1977; (6):53-7. PubMed ID: 304287
    [No Abstract]   [Full Text] [Related]  

  • 33. In vivo effects of thymic hormones (Imunotim) on immunologic parameters of patients with secondary immunodeficiency diseases.
    Crişan M; Stugren C; Gal O; Herold A; Bucurenci N
    Roum Arch Microbiol Immunol; 1992; 51(4):213-24. PubMed ID: 1304826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The primary immunodeficiency diseases: classification, pathogenesis and treatment.
    Gatti RA; Seligmann M
    Turk J Pediatr; 1973 Oct; 15(4):195-215. PubMed ID: 4600502
    [No Abstract]   [Full Text] [Related]  

  • 35. The Gordon Wilson lecture. The history of the development of thymosin: chemistry, biology and clinical applications.
    Goldstein AL
    Trans Am Clin Climatol Assoc; 1977; 88():79-94. PubMed ID: 331647
    [No Abstract]   [Full Text] [Related]  

  • 36. Thymopoietin, ubiquitin and the differentiation of lymphocytes.
    Hadden JW
    Clin Bull; 1975; 5(2):66-7. PubMed ID: 1084233
    [No Abstract]   [Full Text] [Related]  

  • 37. [Theoretical and practical aspects of the clinical use of immunotherapy substituting for thymus functions in man].
    Dabrowski MP; Dabrowska-Bernstein BK; Brzosko WJ
    Pol Tyg Lek; 1983 Mar; 38(13):385-7. PubMed ID: 6605524
    [No Abstract]   [Full Text] [Related]  

  • 38. The endocrine thymus: potential role for thymosin in the treatment of autoimmune disease.
    Goldstein AL; Thurman GB; Cohen GH; Rossio JL
    Ann N Y Acad Sci; 1976; 274():390-401. PubMed ID: 786112
    [No Abstract]   [Full Text] [Related]  

  • 39. [Biological activity and physico-chemical properties of TFK thymic extract].
    Skotnicki AB
    Pol Tyg Lek; 1978 Jul; 33(28):1119-22. PubMed ID: 704411
    [No Abstract]   [Full Text] [Related]  

  • 40. Overview of thymosin activity.
    Marshall GD; Low TL; Thurman GB; Hu SK; Rossio JL; Trivers G; Goldstein AL
    Cancer Treat Rep; 1978 Nov; 62(11):1731-7. PubMed ID: 215305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.